4720-01-477-6767 HOSE ASSEMBLY,NONMETALLIC Index 9999-01-477-6769 COLLATERAL EQUIPMENT,FULL SET

National Stock Number:
6505-01-477-6768

Federal Supply Class:
6505

National Item Identification Number:
014776768

Description:
RETAPLASE,RECOMBINANT FOR INJECT


Manufacturer Information:
00-044089875DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
157895789875DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
8177831XUY5AMERISOURCEBERGEN DRUG CORP
NDC10122-0141-021XUY5AMERISOURCEBERGEN DRUG CORP
6505NCM00020764616DEFENSE MEDICAL STANDARDIZATION BOARD
6505NCM20636464616DEFENSE MEDICAL STANDARDIZATION BOARD
NDC53169-0120-910TF58CENTOCOR INC PHARMACEUTICAL DIV
NDC57894-0040-010TF58CENTOCOR INC PHARMACEUTICAL DIV
NDC67286-0040-011XUY5AMERISOURCEBERGEN DRUG CORP
NDC24477-0041-021XUY5AMERISOURCEBERGEN DRUG CORP
NDC67286-0040-011YU66ESP PHARMA
NDC67286-0040-014YZ75EKR THERAPEUTICS INCORPORATED
NDC24477-0041-024YZ75EKR THERAPEUTICS INCORPORATED
NDC10122-0141-024YZ75EKR THERAPEUTICS INCORPORATED
RETAVASE0TF58CENTOCOR INC PHARMACEUTICAL DIV
RETEPLASE1YU66ESP PHARMA
RETAVASE4YZ75EKR THERAPEUTICS INCORPORATED
RETAVASE KIT4YZ75EKR THERAPEUTICS INCORPORATED


Techincal Specification:
PART NAME ASSIGNED BY CONTROLLING AGENCYRETEPLASE, INTRAVENOUS SOLUTION KIT, 2 VIALS(10 UNITS PER VIAL)
SPECIAL FEATURESRETAVASE IS A TISSUE PLASMINOGEN ACTIVATOR (TPA) INDICATED FOR TREATMENT OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION (STEMI) TO REDUCE THE RISK OF DEATH AND HEART FAILURE; LYOPHILIZED POWDER KIT FOR IV INJECTION; CONTAINS: 2 SINGLE-USE RETAVASE 10-UNIT VIALS; 2-SINGLE-USE PREFILLED STERILE WATER FOR INJECTION; 2 SYRINGE PLUNGERS; 2 STERILE 10ML GRADUATED SYRINGES; 2 STERILE RECONSTITUTION SPIKES; 1 QUICK REFERENCE GUIDE AND 1 PACKAGE INSERT; BOX SHOULD REMAIN SEALED TO PROTECT THE LYOPHILISATE FROM EXPOSURE TO LIGHT. STORE KIT AT 2 TO 25 DEGREES CELSIUS.


Click here to Register for Free 30-day Trial

© 2026 NSN-Now. All rights reserved.    Privacy Policy  |  Contact Us